dr. burtness on frontline immunotherapy in head and neck cancer
Published 5 years ago • 189 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
1:52
dr. burtness on promise of frontline pembrolizumab in metastatic hnscc
-
1:00
dr. burtness on immunotherapy and radioresistance in head and neck cancer
-
1:30
dr. burtness on immunotherapy resistance in head and neck cancer
-
1:29
dr. burtness on challenges facing immunotherapy in head and neck cancer
-
1:05
dr. burtness on combinations of immunotherapy in head and neck cancer
-
1:35
dr. burtness on emerging immunotherapies in head and neck cancer
-
1:57
dr. burtness on the future of immunotherapy in head and neck cancer
-
2:55
audio described: clinical trial tests nivolumab for patients with rare brain and spine cancers
-
1:43
dr. burtness on ongoing trials of immunotherapy in head and neck cancer
-
1:03
dr. burtness on the use of immunotherapy after chemoradiation in head and neck cancer
-
1:22
dr. burtness on immunotherapy and chemotherapy in head and neck cancer
-
1:52
dr. burtness on the development of immunotherapy in head and neck cancers
-
1:23
dr. burtness on the benefit of pembrolizumab in head and neck cancer
-
7:03
pembrolizumab for frontline head and neck cancer: keynote-048 results
-
1:03
dr. bauml discusses immunotherapy in head and neck cancer
-
3:08
keynote-048: pembrolizumab monotherapy for frontline r/m hnscc
-
1:55
dr. burtness on findings of keynote-048 in head and neck cancer
-
2:11
dr. weiss on next steps for immunotherapy in head and neck cancer
-
1:00
dr. ferris on pembrolizumab and nivolumab in head and neck cancer